Rosuvastatin calcium + Fenofibrate
Strength: 5 mg + 145 mg, 10 mg + 145 mg
Dosage Form: Tablets
Description:
Combination therapy for patients with mixed dyslipidemia combining rosuvastatin’s LDL reduction with fenofibrate’s triglyceride lowering.
Key Features:
- Comprehensive lipid management
- Reduces cardiovascular risk
- Convenient fixed-dose tablets
Precautions:
Monitor liver and renal function. Increased risk of muscle toxicity.